Lv1
90 积分 2022-05-17 加入
Tafolecimab: First Approval
6天前
已完结
Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)
6天前
已完结
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
12天前
已完结
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
13天前
已完结
Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials
13天前
已完结
Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
13天前
已完结
Inclisiran for the treatment of dyslipidemia
13天前
已完结
Inclisiran: First Approval
13天前
已完结
Correction to: Inclisiran: First Approval
14天前
已完结
Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels
18天前
已完结
皖公网安备34019202002308
